Scientific Program Diabetes and Nutritions

Day I (10^th of April 2025)

08:00

RESEARCH CENTERS
8:00 – 12:00 Hands-on Training

Echocardiography

Speckle tracking Echocardiography
3D Echocardiography

Oana Mirea, Despina Toader, Diana Hădăreanu
Supported by MEDIST

Insulin pumps
Delia Pintilei Reurean, Maria Magdalena Roșu, Diana Protasiewicz Timofticiuc, Theodora Gheonea
Supported by Medtronic

13:00

AULA MAGNA
Innovation and multidisciplinarity in obesity management and the future of health

13.00-13.15 Official opening
- Dan Gheonea, Ionuț Donoiu, Mihaela Vladu
13.15-13.30 G6 UMF Alliance – LAWG – Ministry of Health
- Health Innovation Hub: Signing the additional act to extend the collaboration between founding members
- Dan Gheonea – President of G6-UMF Association
- Teodor Blidaru – Project Manager Health Innovation Hub
- Radu Rășinar, Frank Loeffler – Representants of LAWG

Supported by Novo Nordisk

13.30-15.30 Multidisciplinary Management of Obesity
- Cătălina Poiana, Bogdan Timar, Liana Gheorghe, Bogdan Mateescu, Dan Gaiță, Dan Gheonea, Mihaela Vladu, Ionuț Donoiu, Xenia Negrea
15.30-16.00 Break
16.00-16.30 Pipeline drugs in obesity
- Bogdan Timar
16.30-17.30 Artificial intelligence (AI) – Revolutionizing Healthcare
- Adrian Săftoiu, Ștefan Busnatu, Delia Pintilei
17.30-18.00 Why a gastroenterologist should treat obesity?
- Cristina Cijevschi
18.00-18.30 The Physician and Pharmacist’s Hub – unique concept in Oltenia
- Tudorel Ciurea

Day II (11^th of April 2025)

DIABETES/ENDOCRINOLOGY HALL – 2nd Floor

08:00

Obesity: diagnostic and complications
Chairmen: Cătălina Poiană, Anca Pantea Stoian

08.00 – 08.20 Obesity and its complications
Anca Pantea Stoian
08.20 - 08.40 Obesity risks and care stratification - recommendations of the Romanian Obesity Forum 2025
Cornelia Bala
08.40 – 09.00 Neurohormonal control of energy balance
Mihaela Popescu
09.00 - 09.20 Metabolic syndrome in postmenopausal status
Cătălina Poiană

09:20

Current approaches in the management of peripheral neuropathy (Sunwave)
Mihaela Vladu

09:40

DAPAGLIFLOZIN, First Step for Cardio-Renal Prevention in T2D (AstraZeneca)
Mihaela Vladu

10:10

Obesity: a health problem of the modern world
Chairmen: Cornelia Bala, Diana Clenciu

10.10 - 10.30 The conceptual path of excess weight from apparent well-being to certain illness
Diana Clenciu
10.30 - 10.50 Burden of emotional dysregulation on body weight
Cristina Lăcătușu
10.50 – 11.10 Obesity and stigma - psychopathological and social implications
Victor Gheorman
11.10 - 11.30 New standards of diagnostic and clinical implications of obesity
Gabriela Radulian, Andreea Andrița

11:30

Break

12:00

Obesity & Cardiovascular Disease
Chairmen: Doina Catrinoiu, Romulus Timar

12.00 – 12.20 What’s new about obesity and heart failure?
Doina Catrinoiu
12.20 – 12.40 Tracing the adipose pathway to heart failure in diabetes
Adina Braha
12.40 – 13.10 Obesity and heart failure – process of a complex clinical puzzle
Romulus Timar

13:10

Mounjaro – Revolutionize Obesity Care (Eli Lilly)
Chairman: Dan Gheonea

Mounjaro - The First and Only GIP/GLP-1 Receptor Agonist Available in Obesity Care

Mihaela Vladu

Tirzepatide - SURMOUNTing Evidences in Obesity Care

Bogdan Timar

14:10

Lunch break

15:00

Management of Obesity and Diabetes

15.00 - 15.30 Results from current medical practice of intensifying treatment with Toujeo® in adults with T2DM inadequately controlled with GLP-1 Ars (Sanofi)
Mihaela Vladu
15:30 - 16.00 From Heart to SOUL: Proven Cardiovascular Benefits of Oral Semaglutide (Novo Nordisk)
Romulus Timar, Mihaela Vladu
16:00 - 16:15 The vicious circle under control - Strategies for reducing blood pressure in patients with diabetes (Servier)
Diana Clenciu
16.15 - 16.30 Cardiovascular risk of patients with diabetes (Krka)
Mihaela Vladu

16:30

Obesity and Diabetes
Chairmen: Cristian Guja, Cristina Lăcătușu

16.30 – 16.50 Evolution of diabetes in adult population - 5-year update
Antoanela Curici
16.50 – 17.10 New therapeutic perspectives in atherogenic dyslipidemia
Laura Gaiță
17.10 – 17.30 Possible benefits of GLP-1 agonists and SGLT-2 inhibitors in patients with type 1 diabetes
Cristian Guja
17.30 – 17.50 Continuous glucose monitoring systems - indications and benefits for different categories
Andrada Mihai
17.50 – 18.05 Continuous glycemic monitoring in obesity
Viviana Elian

Day III (12^th of April 2025)

DIABETES/ENDOCRINOLOGY HALL – 2nd Floor

08:00

Obesity – Clinical Implications (I)
Chairmen: Mihaela Vladu, Constantin Kamal

8.00 – 8.15 Obesity – diabetes – cancer: an unfortunate association
Michael Schenker
8.15 – 8.30 The burden of cancer in MASLD
Ion Cristian Efrem
8.30 – 8.45 Cardiovascular burden in the patient with MASLD
Vlad Pădureanu
8.45 – 9.00 The role of the family doctor in the multidisciplinary team in the management of the patient with obesity
Constantin Kamal

09:00

Obesity – Clinical Implications (II)
Chairmen: Beatrice Mahler, Oana Albai

9.00 – 9.20 Sleep apnea syndrome - factor of circadian rhythm imbalance: metabolic consequences
Beatrice Mahler
9.20 – 9.40 Microbiota disorders and its relationship with sleep apnea syndrome
Diana Protasiewicz Timofticiuc
9.40 – 10.00 Fatty kidney - a new concept
Mihaela Vladu
10.00 – 10.20 Advances and Challenges in the management of diabetic kidney disease
Oana Albai

10:20

Break

10:40

Obesity – Management
Chairmen: Bogdan Timar, Alexandra Sima

10.40 – 11.00 From diet to daily habits: a lifestyle approach to obesity
Maria Magdalena Roșu
11.00 – 11.20 Intermittent fasting in the 21st century
Alexandra Sima
11.20 – 11.40 Practical considerations in obesity
Delia Reurean Pintilei
11.40 – 12.00 Obesity treatment - new perspectives
Bogdan Timar

12:00

Therapeutic Perspective of Diabetes and Its Complications

12.00 – 12.15 Treatment recommendations in Diabetic Neuropathy – correctly understanding the guidelines (Worwag)
Mihaela Vladu
12.15 – 12.30 Integrative multidisciplinary approaches: management of diabetic neuropathy (Naturalis)
Diana Protasiewicz Timofticiuc
12.30 – 12.45 Management of microvascular complications in diabetes mellitus: an integrated approach (AlfaSigma)
Maria Magdalena Roșu
12.45 – 13.00 A new therapeutic approach in the management of dysbiosis associated with metabolic syndrome (Vedra)
Adina Mitrea

13:00

Lunch break

14:00

10 years of cardiac, renal and metabolic benefits with Jardiance (Boehringer)
Mihaela Vladu, Eugen Țieranu

14:20

Obesity – Clinical Implications (III)
Chairmen: Adina Mitrea, Maria Magdalena Roșu

14.20 – 14.35 Genetic factors in obesity
Florin Burada
14.35 – 14.50 Obesity in the pediatric population - a worrying reality
Radu Diaconu
14.50 – 15.05 The Atlas Syndrome: A burden too heavy for the joints to bear
Florin Vreju
15.05 – 15.20 Sarcopenic obesity
Adina Mitrea
15.20 – 15.35 MDTs in optimizing diabetes in pregnancy outcomes
Stefania Tudorache
15.35 – 15.50 Influence of BMI on the results of semi-rigid retrograde ureteroscopy in the treatment of ureteral lithiasis
George Mitroi
15.50 – 16.05 Erectile dysfunction in people with metabolic disorders
Andrei Pănuș

16:05

Break

16:30

Case Reports
Chairman: Diana Clenciu, Diana Protasiewicz Timofticiuc

16.30 – 16.45 Obesity – hard to beat
Andreea Cioroianu
16.45 – 17.00 The unseen face of atherosclerosis in metabolic diseases
Diana Protasiewicz Timofticiuc
17.00 – 17.15 The impact of metabolic syndrome elements on heart rate
Gheonea Theodora
17.15 – 17.30 Sustainable weight loss through lifestyle changes: A case report on non-pharmacological intervention
Maria Magdalena Roșu
17.35 – 17.45 Discussions

Day IV (13^th of April 2024)

09:00

9.00-12.00 Breakfast at UMF’s

Magda Roșu, Theodora Gheonea

Healthy culinary practices at Nutrition and Dietetics in UMF Craiova

Orele programului sunt exprimate in ora României